Inventaire - your friends and communities are your best library

Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia

author

Vince D. Calhoun

2000 -

Jingyu Liu

mű, amelyben megjelent: Frontiers in Psychiatry

date of publication: 2017-06-12

main subject: skizofrénia

Cites articles 25

Date

Title

Authors

2017-05-01

Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
2016-06-15

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

Philip McGuire, Kate Merritt, Matthew Taylor, Matthew J. Kempton
2016-02-08

Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence

Joseph P Schacht, Perry F Renshaw
2015-06-10

Event-related dynamics of glutamate and BOLD effects measured using functional magnetic resonance spectroscopy (fMRS) at 3T in a repetition suppression paradigm

Dace Apšvalka, Matthew Clemence, Paul G. Mullins
2015-03-19

Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia
2014-07-24

Biological insights from 108 schizophrenia-associated genetic loci

Hannelore Ehrenreich, Richard Bruggeman, Ingrid Agartz, Tune H Pers
2013-11-21

A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra

Caroline D. Rae
2013-10-01

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study

Camilo de la Fuente-Sandoval, Ariel Graff-Guerrero, Pablo León-Ortiz
2013-01-01

Glutamate-dependent neuroglial calcium signaling differs between young and adult brain

Maiken Nedergaard
2011-04-21

Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons

Robert Fredriksson
2011-03-31

Relationship between genetic variation in the glutaminase gene GLS1 and brain glutamine/glutamate ratio measured in vivo

Perry F Renshaw, Jordan W Smoller
2011-03-31

Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies

Stephen J Wood, Andrew M. McIntosh, Stephen M Lawrie, Edward T. Bullmore
2011-02-28

Test-retest reliability and reproducibility of short-echo-time spectroscopic imaging of human brain at 3T.

Vince D. Calhoun, Eswar Damaraju
2011-04-21

Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system

Andrea Schmitt, Peter Falkai, Thomas Schneider-Axmann, Alkomiet Hasan, Oliver Gruber
2010-04-01

International consensus study of antipsychotic dosing

David M Gardner, Andrea L Murphy
2009-03-01

Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI)

Andrew A Maudsley, Varan Govind
2006-06-01

Use of tissue water as a concentration reference for proton spectroscopic imaging

Leslie Morrison, Paul G. Mullins
2005-01

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Daniel R. Weinberger
2004-03-01

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

Ralitza Gueorguieva, John H Krystal
2001-06-01

Automatic quantitation of localized in vivo 1H spectra with LCModel.
2001-01

Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus

Tilman Breiderhoff, Dominique Engel, Holger Jahn, Reinhard Jahn
1989-05

A rating scale for drug-induced akathisia
1987

The positive and negative syndrome scale (PANSS) for schizophrenia
1982-04-01

Research diagnoses for tardive dyskinesia,Research Diagnoses for Tardive Dyskinesia
1970-01-01

A rating scale for extrapyramidal side effects

Article - wd:Q33785717

Welcome to Inventaire

the library of your friends and communities

learn more